Potential coronavirus therapeutic could be first available for critical cases: CytoDyn CEO
CytoDyn CEO Nader Pourhassan discusses company being in advanced stages of clinical trials for coronavirus antibody treatment.
Tuesday, October 20, 2020
Potential coronavirus therapeutic could be first available for critical cases: CytoDyn CEO
Potential coronavirus therapeutic could be first available for critical cases: CytoDyn CEO
CytoDyn CEO Nader Pourhassan discusses company being in advanced stages of clinical trials for coronavirus antibody treatment.
Related Posts:
Health insurer Centene to buy smaller rival WellCare for $15.27 billion- The Latest: Tusk: We should still welcome UK at EU elections
- Swedbank may have misled U.S. over client links to Panama Papers: Swedish TV
- Stocks flat, bond yields lower, all eyes on central banks
- Commerzbank CEO, board took a pay cut in 2018
0 comments:
Post a Comment